CYTOMEGALOVIRUS ANTERIOR UVEITIS

Clinical trials for CYTOMEGALOVIRUS ANTERIOR UVEITIS explained in plain language.

Never miss a new study

Get alerted when new CYTOMEGALOVIRUS ANTERIOR UVEITIS trials appear

Sign up with your email to follow new studies for CYTOMEGALOVIRUS ANTERIOR UVEITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Eye drop vs. pill: race to stop a virus that steals sight

Disease control Terminated

This study aimed to find the best way to treat a painful and potentially blinding eye infection called cytomegalovirus (CMV) anterior uveitis. It compared an oral antiviral pill (valganciclovir) against an antiviral eye drop (ganciclovir 2%) and a placebo in 51 adults with a conf…

Matched conditions: CYTOMEGALOVIRUS ANTERIOR UVEITIS

Phase: PHASE2, PHASE3 • Sponsor: University of California, San Francisco • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

CYTOMEGALOVIRUS ANTERIOR UVEITIS

Get alerted when new CYTOMEGALOVIRUS ANTERIOR UVEITIS trials appear

Eye drop vs. pill: race to stop a virus that steals sight